LONDON, March 1, 2019
Recent research by Satipharm identified significant confusion in this cannabis-related market due partly to the multitude of products and formats being sold, often with unsubstantiated claims or a lack of information regarding dose, quality or bioavailability of the CBD.
Jonathan Hartshorn, CEO of Satipharm commented,
"We can see from online forums that people are craving trustworthy advice about CBD. At Satipharm, we believe that CBD should be easily understood. We have made this CBD Buying Guide freely available to give people a clear understanding of the range of factors to consider when purchasing CBD and empower them to buy CBD with confidence."
Satipharm CBD Gelpell® capsules are made in Switzerland according to the stringent international requirements of Good Manufacturing Practice (GMP), and take the guess work out of dosing compared to bottled oils and other CBD formats. As well as providing a trusted source of CBD, Satipharm's Gelpell® capsules offer better value through their higher bioavailability compared to other formulations, meaning consumers pay less per mg of absorbed CBD with Satipharm than with other products available.
Satipharm's free CBD Buying Guide provides essential advice to anyone who wants to evaluate CBD oil for sale:
Satipharm's free CBD Buying Guide is quick and easy to read and will help you make decisions about how to introduce CBD into your daily routine or replace your current product with a more effective form of CBD.
Brand and Digital Manager